[128] By contrast, other DAT inhibitors such as bupropion have not been noticed to exhibit this result.[129] These observations have prompted the hypothesis that methylphenidate may well act as a "DAT inverse agonist" or "damaging allosteric modifier with the DAT" by reversing the way with the dopamine efflux with the DAT at better dosages.[one hun